| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1106947602 |
| P356 | DOI | 10.1186/S13287-018-0969-Z |
| P932 | PMC publication ID | 6137884 |
| P698 | PubMed publication ID | 30217223 |
| P50 | author | Giulio Pompilio | Q40615922 |
| Erica Rurali | Q56348612 | ||
| Valentina Catto | Q59249634 | ||
| Corrado Carbucicchio | Q61126065 | ||
| Piergiuseppe Agostoni | Q61713328 | ||
| P2093 | author name string | Paolo Scacciatella | |
| Giuseppe Gaipa | |||
| Felice Achilli | |||
| Matteo Parma | |||
| Alberto Bestetti | |||
| Fabrizio Celeste | |||
| Daniela Belotti | |||
| Alice Bonomi | |||
| Beatrice Bassetti | |||
| Elisa Gambini | |||
| Maurizio Arosio | |||
| Stefano Righetti | |||
| Lorenza Biava | |||
| P2860 | cites work | Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 | Q28187887 |
| Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor | Q28236903 | ||
| Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis | Q30729604 | ||
| Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial | Q33950809 | ||
| Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. | Q34691429 | ||
| Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis | Q34804229 | ||
| Fatality, morbidity and quality of life in patients with refractory angina pectoris | Q35010712 | ||
| Predictors of long-term clinical endpoints in patients with refractory angina | Q35135665 | ||
| Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia | Q35206801 | ||
| Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris--a multicenter study. | Q35570603 | ||
| Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial | Q35810820 | ||
| Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. | Q36055443 | ||
| Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy. | Q36162831 | ||
| Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 | ||
| Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial | Q36694346 | ||
| Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results. | Q37085825 | ||
| Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience | Q37217902 | ||
| GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy | Q37311008 | ||
| Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells | Q37976449 | ||
| Treatment of refractory angina in patients not suitable for revascularization | Q38173640 | ||
| The CD133+ cell as advanced medicinal product for myocardial and limb ischemia. | Q38228388 | ||
| Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial | Q38381605 | ||
| Effects of Transendocardial Delivery of Bone Marrow-Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial. | Q38384000 | ||
| Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results | Q38655874 | ||
| Revascularization in Patients With Severe Left Ventricular Dysfunction: Is the Assessment of Viability Still Viable? | Q38867290 | ||
| Cell therapy for heart disease after 15 years: Unmet expectations. | Q39149897 | ||
| Long-term survival in patients with refractory angina | Q39227491 | ||
| Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines | Q39639358 | ||
| Autologous CD34+ Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study | Q39790202 | ||
| CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms | Q40168375 | ||
| Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction | Q41871395 | ||
| Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine | Q42854848 | ||
| The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina | Q43818391 | ||
| Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials | Q44493479 | ||
| Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants | Q45278756 | ||
| Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. | Q46496807 | ||
| Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials | Q47190217 | ||
| Cell Therapy for Refractory Angina: A Reappraisal. | Q48155875 | ||
| A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). | Q48657008 | ||
| Improvement of Local Cell Delivery Using Helix Transendocardial Delivery Catheter in a Porcine Heart. | Q50864511 | ||
| Novel Application of 3-Dimensional Real-Time Cardiac Imaging to Guide Stem Cell-Based Therapy. | Q50962762 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
| Clonal Analysis Reveals a Common Progenitor for Endothelial, Myeloid, and Lymphoid Precursors in Umbilical Cord Blood | Q51897883 | ||
| Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial. | Q53050821 | ||
| Bone Marrow Cell Therapy for Ischemic Heart Disease: The Never Ending Story. | Q54258496 | ||
| Global position paper on cardiovascular regenerative medicine | Q56985687 | ||
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
| Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study | Q72573690 | ||
| Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction | Q74288420 | ||
| CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells | Q79317344 | ||
| Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results | Q80333368 | ||
| Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease | Q82727493 | ||
| Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double | Q83582313 | ||
| Power Is Nothing Without Control: The Enduring Search for the Best Cell in Cardiac Cell Therapy at a Crossroads | Q88546834 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular medicine | Q3523816 |
| P304 | page(s) | 235 | |
| P577 | publication date | 2018-09-14 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO) | |
| P478 | volume | 9 |
| Q91799087 | Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) | cites work | P2860 |
Search more.